Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
- Cid-Silva, P.
- Fernández-Bargiela, N.
- Margusino-Framiñán, L.
- Balboa-Barreiro, V.
- Mena-De-Cea, Á.
- López-Calvo, S.
- Vázquez-Rodríguez, P.
- Martín-Herranz, I.
- Míguez-Rey, E.
- Poveda, E.
- Castro-Iglesias, Á.
ISSN: 1742-7843, 1742-7835
Year of publication: 2019
Volume: 124
Issue: 4
Pages: 479-490
Type: Article